Case File №
#VI-2026-0700
Lux Synth Aminos
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
36 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A Great | 2 | 8.2 | 7.2 | 9.1 | 22 May 2026 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 1 | 8.4 | 8.4 | 8.4 | 28 Mar 2025 |
| 5-amino-1MQ | X N/A | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 |
| Andarine S4 | X N/A | 1 | 4.7 | 4.7 | 4.7 | 2 Jul 2025 |
| Arimidex (Anastrozole) | X N/A | 1 | 9.1 | 9.1 | 9.1 | 24 Apr 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 1 | 8.0 | 8.0 | 8.0 | 3 Jun 2025 |
| Botulinum toxin | X N/A | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| Cerebrolysin | X N/A | 1 | 8.4 | 8.4 | 8.4 | 2 Jul 2025 |
| CJC-1295 With DAC | X N/A | 1 | 9.3 | 9.3 | 9.3 | 2 Jul 2025 |
| Dihexa | X N/A | 1 | 8.3 | 8.3 | 8.3 | 9 Jun 2025 |
| IGF-1 LR3 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 20 Jun 2025 |
| KissPeptin-10 | X N/A | 1 | 9.0 | 9.0 | 9.0 | 17 Dec 2024 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 9.5 | 9.5 | 9.5 | 27 Feb 2025 |
| KPV Oral | X N/A | 1 | 8.5 | 8.5 | 8.5 | 27 Feb 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 |
| MENT (Trestolone Acetate) | X N/A | 1 | 8.0 | 8.0 | 8.0 | 28 Mar 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 8.3 | 8.3 | 8.3 | 6 May 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 9.7 | 9.7 | 9.7 | 13 Feb 2025 |
| PEG MGF | X N/A | 1 | 9.6 | 9.6 | 9.6 | 3 Jul 2025 |
| Prostamax | X N/A | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 7.0 | 7.0 | 7.0 | 9 Jun 2025 |
| Romosozumab | X N/A | 1 | 7.8 | 7.8 | 7.8 | 2 Jul 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 9.0 | 9.0 | 9.0 | 16 Mar 2025 |
| Selank | X N/A | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 |
| SLU-PP-332 | X N/A | 1 | 8.2 | 8.2 | 8.2 | 17 Dec 2024 |
| SR9009 | X N/A | 1 | 7.7 | 7.7 | 7.7 | 2 Apr 2025 |
| SS-31 (Elamipretide) Raw | X N/A | 1 | 8.6 | 8.6 | 8.6 | 16 Mar 2025 |
| Super Shred | X N/A | 1 | 9.9 | 9.9 | 9.9 | 7 May 2025 |
| T3 (Liothyronine) | X N/A | 1 | 7.7 | 7.7 | 7.7 | 27 Feb 2025 |
| Thymalin | X N/A | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 |
| TriTren 225 | X N/A | 1 | 9.0 | 9.0 | 9.0 | 7 May 2025 |
| Turinabol | X N/A | 1 | 9.4 | 9.4 | 9.4 | 20 Jun 2025 |
| Vilon | X N/A | 1 | 8.8 | 8.8 | 8.8 | 20 Jun 2025 |
| VIP | X N/A | 1 | 7.7 | 7.7 | 7.7 | 20 Jun 2025 |
Exhibit II
Evidence Log
37 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | SR9009 | 10.0 A | 10mg | 10.0mg | +0.2% | 96.29% | 1ewjzg | Lab A | Community |
| 24 May 2026 | N-Acetyl Epitalon Amidate | 7.7 A | 15mg | 16.7mg | +11.4% | 98.14% | lh3mhr | Lab C | Public |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 9.6 A | 20mg | 19.0mg | -5.1% | 95.20% | zbmomd | Lab C | Community |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 9.4 A | 15mg | 13.8mg | -7.7% | 99.75% | ha2mqj | Lab G | Public |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.6 A | 30mg | 28.5mg | -5.2% | 99.77% | oc6r6q | Lab B | Community |
| 24 May 2026 | Cerebrolysin | 10.0 A | 5mg | 4.7mg | -6.6% | 96.98% | k5de01 | Lab F | Public |
| 24 May 2026 | CJC-1295 With DAC | 10.0 A | 2mg | 2.1mg | +2.5% | 98.17% | 36qid2 | Lab G | Public |
| 24 May 2026 | SS-31 (Elamipretide) Raw | 8.8 A | 10g | 11.0g | +10.0% | 95.39% | 3nus3b | Lab G | Community |
| 24 May 2026 | Thymalin | 8.0 A | 2mg | 2.0mg | -2.4% | 96.04% | 1dom7m | Lab F | Public |
| 23 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 8.1 A | 100mg/ml | 117.1mg/ml | +17.1% | 99.68% | bmlogy | Lab E | Public |
| 23 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 8.5 A | 1g | 1.2g | +23.7% | 97.13% | jcdntq | Lab E | Community |
| 23 May 2026 | SLU-PP-332 | 7.5 A | 100mg | 98.6mg | -1.4% | 98.32% | 120tvj | Lab A | Community |
| 22 May 2026 | Retatrutide | 7.2 A | 30mg | 33.8mg | +12.7% | 99.61% | LSUSA000100 | Lab E | Vendor |
| 22 May 2026 | Retatrutide | 9.1 A | 30mg | 32.3mg | +7.7% | 99.90% | LSUSA000100 | Lab E | Vendor |
| 20 May 2026 | VIP | 5.6 B | 2mg | 2.4mg | +22.3% | 98.32% | azwvmu | Lab B | Public |
| 19 May 2026 | Selank | 10.0 A | 10mg | 9.3mg | -6.6% | 98.84% | 7vi5s2 | Lab E | Community |
| 29 Jan 2026 | Prostamax | 9.5 A | 2mg | 2.4mg | +20.6% | 97.12% | 0zpxus | Lab C | Community |
| 29 Jan 2026 | Turinabol | 9.7 A | 20mg | 19.4mg | -3.0% | 97.32% | 8m67zg | Lab G | Public |
| 26 Jan 2026 | Dihexa | 7.2 A | 20mg | 23.6mg | +17.9% | 96.47% | yzmiiz | Lab E | Community |
| 26 Jan 2026 | LGD-4033 (Ligandrol) | 7.6 A | 50mg | 45.4mg | -9.3% | 99.17% | n8ht8k | Lab F | Public |
| 9 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.1 A | 10mg | 11.1mg | +11.5% | 95.32% | fkqg7x | Lab E | Community |
| 9 Jan 2026 | T3 (Liothyronine) | 7.5 A | 50mg | 50.7mg | +1.4% | 98.73% | h8ch3a | Lab B | Public |
| 7 Jan 2026 | KPV Oral | 8.9 A | 100mg | 110.6mg | +10.6% | 97.82% | f2rh8p | Lab E | Public |
| 7 Jan 2026 | TriTren 225 | 10.0 A | 200mg/ml | 249.5mg/ml | +24.8% | 95.09% | y74436 | Lab B | Public |
| 6 Jan 2026 | Botulinum toxin | 5.6 B | 5mg | 6.0mg | +20.3% | 99.20% | d81a8k | Lab D | Community |
| 29 Dec 2025 | MENT (Trestolone Acetate) | 9.1 A | 300mg/ml | 310.4mg/ml | +3.5% | 97.24% | j5qa18 | Lab A | Community |
| 12 Dec 2025 | Andarine S4 | 6.7 A | 10mg | 8.9mg | -11.5% | 97.26% | bxfsz2 | Lab E | Public |
| 12 Dec 2025 | KissPeptin-10 | 6.7 A | 5mg | 5.0mg | -0.9% | 99.41% | 6x17gv | Lab B | Public |
| 5 Dec 2025 | IGF-1 LR3 | 6.0 A | 2mg | 1.9mg | -6.0% | 99.68% | tef6nr | Lab F | Public |
| 5 Dec 2025 | Super Shred | 8.3 A | 250mg/ml | 293.4mg/ml | +17.4% | 96.45% | ypnwh6 | Lab A | Community |
| 23 Nov 2025 | Vilon | 9.5 A | 5mg | 4.6mg | -7.6% | 99.03% | d8d0bw | Lab F | Public |
| 17 Nov 2025 | Arimidex (Anastrozole) | 9.6 A | 100mg | 119.4mg | +19.4% | 98.15% | qglvuu | Lab G | Community |
| 17 Nov 2025 | Romosozumab | 7.5 A | 2mg | 2.3mg | +12.5% | 96.84% | whbavs | Lab F | Community |
| 4 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 10.0 A | 5mg | 4.5mg | -10.1% | 97.63% | n4u0q2 | Lab G | Public |
| 9 Oct 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 8.0 A | 100mg/ml | 90.4mg/ml | -9.6% | 98.14% | 679oiy | Lab C | Community |
| 3 Oct 2025 | 5-amino-1MQ | 10.0 A | 30mg | 34.0mg | +13.3% | 99.01% | 4zai67 | Lab C | Community |
| 3 Oct 2025 | PEG MGF | 10.0 A | 50mg | 45.1mg | -9.9% | 98.85% | 2ytzqf | Lab E | Public |
— END OF EVIDENCE LOG —